Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of the Impact of the COronaVirus Disease 2019 (COVID-19) Epidemic on Patients With Myeloproliferative Neoplasias

NCT04416438 is registered in ClinicalTrials.gov with French Innovative Leukemia Organisation as lead sponsor.

NCT NCT04416438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04416438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of the Impact of the COronaVirus Disease 2019 (COVID-19) Epidemic on Patients With Myeloproliferative Neoplasias
Lead sponsor
French Innovative Leukemia Organisation
Phase
Observational
Overall status
Completed
Start date
May 18, 2020
Completion date
September 1, 2022
Enrollment
1,793 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 infection, myeloproliferative neoplasm